Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby, Marion Mafham, Louise Linsell, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 21, pp. 2030-2040
Open Access | Times Cited: 1175

Showing 1-25 of 1175 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Hongchao Pan, Richárd Pető, Ana‐Maria Henao‐Restrepo, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 6, pp. 497-511
Open Access | Times Cited: 2497
Severe Covid-19
David Berlin, Roy M. Gulick, Fernando J. Martínez
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2451-2460
Closed Access | Times Cited: 1390
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10285, pp. 1637-1645
Open Access | Times Cited: 1016
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Romina Libster, Gonzalo Pérez Marc, Diego Wappner, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 7, pp. 610-618
Open Access | Times Cited: 858
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 685
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, et al.
The Lancet (2021) Vol. 397, Iss. 10274, pp. 605-612
Open Access | Times Cited: 531
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 513
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19
Ning Rosenthal, Zhun Cao, Jake Gundrum, et al.
JAMA Network Open (2020) Vol. 3, Iss. 12, pp. e2029058-e2029058
Open Access | Times Cited: 444
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Hongchao Pan, Richard Peto, Quarraisha Abdool Karim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 431
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 431
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
Wesley H. Self, Matthew W. Semler, Lindsay Leither, et al.
JAMA (2020) Vol. 324, Iss. 21, pp. 2165-2165
Open Access | Times Cited: 401
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 3, pp. e219-e234
Open Access | Times Cited: 360
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 399, Iss. 10325, pp. 665-676
Open Access | Times Cited: 354
COVID-19 in early 2021: current status and looking forward
Chengdi Wang, Zhoufeng Wang, Guangyu Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 305
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Peter Horby, Guilherme Pessoa-Amorim, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 302
Lung transplantation for patients with severe COVID-19
Ankit Bharat, Melissa Querrey, Nikolay S. Markov, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 574
Open Access | Times Cited: 295
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 272
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 399, Iss. 10320, pp. 143-151
Open Access | Times Cited: 257
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 400, Iss. 10349, pp. 359-368
Open Access | Times Cited: 254
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Abdul Aleem, Abdul Samad, Amy Slenker
(2021) Vol. 01, pp. 01-01
Closed Access | Times Cited: 242
Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science
Jon Agley, Yunyu Xiao
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 235
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, et al.
Science Advances (2020) Vol. 6, Iss. 50
Open Access | Times Cited: 233
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Perrine Janiaud, Cathrine Axfors, Andreas M. Schmitt, et al.
JAMA (2021) Vol. 325, Iss. 12, pp. 1185-1185
Open Access | Times Cited: 227
Page 1 - Next Page

Scroll to top